Publisher
Springer Berlin Heidelberg
Reference82 articles.
1. Abderhalden RT, Bukowski RM, Groppe CW, Hewell JS, Weick JK: Streptozotocin (STZ) and 5-Fluorouracil (5 FU) with and without mitomycin-C (Mito) in the treatment of pancreatic adenocarcinoma. Proc ASCO 18:301 (1977).
2. Astler VB, Coller FA: The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 139:346 (1954).
3. Baker LH, Matter R, Talley R, Vaitkevicius V: 5-FU vs 5-FU and me-CCNU in gastrointestinal cancers. A phase III study of the South West Oncology Group. Proc Am Soc Clin Oncol 16:229 (1975).
4. Baker LH, Talley RW, Matter R, Lahane DE, Ruffner BW, Jones SE, Morrison FS, Stephens RL, Gehan EA, Vaitkevicius VK: Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs Methyl-CCNU plus bolus weekly 5 FU. Cancer (Philad) 38:1 (1976).
5. Bancewicz J, Caiman KC, Macpherson SG, Mc Ardle CS, Mc Vie JG, Sonkop M: Adjuvantchemotherapy and immunotherapy for colorectal cancer, preliminary communication. J Roy Soc Med 73:197 (1980).